Hızlı Erişim


Bu Dergi DOI ve Crosscheck üyesidir


Abstract


OBEZ HASTALARDA ORLİSTAT TEDAVİSİNİN LİPİD PROFİLİ ÜZERİNE ETKİSİ

Orlistat inhibits gastric and pancreatic lipases in the lumen of the gastrointestinal tract to decrease absorption of dietary fat. Some studies have shown that orlistat can reduce total cholesterol (TC), LDL cholesterol (LDL-C), and triglyceride (TG) levels after long or short-term use, regardless of weight loss.This study aims to investigate the effect of orlistat on lipid profile in obese patients. Thirty patients with the body mass index (BMI) of 40 or more were included. In addition to the low-calorie diet, 120 mg orlistat treatment three times a day was added. Lipid levels and weights were measured at baseline and after 8 weeks. Twenty patients were female and the mean age was 37.7±14.3 years. The mean BMI was 45.3±5.5 at the beginning and 44.4±5.4 (p=0.6) after 2 months. The TC decreased from 217.6±45.3 mg/dl to 196.8±31.4 mg/dl (p=0.1), TG decreased from 190.3±49.8 mg/dl to 155.6±40.3 mg/dl (p=0.045), and the LDL-C decreased from 134.33±38.8 mg/dl to 116.9±29.7 mg/dl (p=0.18). HDL-C level was 50.5±14.6 mg/dl at baseline and 51.2±14.6 mg/dl after 2 months (p=0.8). At the end of the 2-months therapy with orlistat 120 mg three times a day, only a statistically significant decrease was achieved in TG levels. There was no statistically significant change in BMI. Although recently published studies show that orlistat has a lowering effect on TG, TC and LDL-C levels, in our study we only observed a significant decrease in TG levels. The achievement of this result without significant weight loss indicates that this effect may be independent of weight loss. To evaluate the effect of orlistat on the lipid profile, studies involving more patients and investigating its use for a longer time are needed.



Keywords
Orlistat,obesity, triglyceride, lipids



Kaynakça 1. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance and impaired cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res. 2000;8:49-61. 2. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Engl J Med. 1995;333:677-685. 3. Tanakol R. Obezite Tedavisinde Orlistat. Turkish Journal of Endocrinology and Metabolism. 2003;2:87-97. 4. Guerciolini R. Mode of action of orlistat. Int J Obes. 1997;3:12-23. 5. A Ballinger. Orlistat in the treatment of obesity. Expert Opin Pharmacother. 2000;1:841-847. 6. Kelley DE, Bray GA, Pi-Sunyer. Clinical efficacy of orlistat therapy in owerweight and obese patients with insulin treated-type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care. 2002;25:1033-1041. 7. Derosa G, Mugellini A, Ciccarelli L, Fogari R. Randomized, double-blind, placebo-controlled comparison of action of orlistat, fluvastatin, or both on anthropometric measurements, blood pressure, and lipid profili, in obese patients with hypercholesterolemia prescribed a standardized diet. Clin Therapeutics. 2003;25:1107-1122. 8. Muls E, Kolanowski J, Scheen E, Van Gaal L. The effects of orlistat on weight and serum lipids in obese patients with hypercholestrolemia: a randomized, double blind, placebo controlled, multicentre study. Int J Obes Relat Metab Disord. 2001;25:1713-1721 9. Bloch KV, Salles KF, Muxfeldt ES, da Rocha Nogueria A. Orlistat in hypertensive overweight / obese patients: results of a randomized clinical trial. J Hypertens. 2003;21:2159-2165. 10. Varol E, Şahin M, Aslan SM, Özaydın M, Altınbaş A. Obez hastalarda kısa dönem orlistat tedavisinin plazma lipid düzeylerine etkisi. S.D.Ü. Tıp Fak. Derg. 2006;13:1-3 11. Wierzbicki AS, Reynolds TM, Crook MA. Usefulness of orlistat in the treatment of severe hypertriglyceridemia. Am J Cardiol. 2002;89:229-231. 12. Mittendorfer B, Ostlund RE, Patterson BW, Klein S. Orlistat inhibits dietary cholesterol absorbtion. Obes Res. 2001;9:599-604

Gelişmiş Arama


Duyurular

    ***********************

    DEĞERLİ BİLİM 

    İNSANLARI!

    mail mail mail mail mail

    Dergimizin Mayıs sayısı 

    (27.05.2021)

    yayınlanmıştır.

    mail mail mail mail mail

    DEĞERLİ BİLİM 

    İNSANLARI!

    mail mail mail mail mail

    Dergimizin

    Temmuz Sayısı 

    İçin Makalenizi  

    Sisteme Yükleyebilirsiniz.

    mail mail mail mail mail

     



Adres :Göztepe Mah., Beykoz, İstanbul/TURKEY
Telefon :+90 555 005 92 85 Faks :+90 216 606 32 75
Eposta :info@euroasiajournal.org

Web Yazılım & Programlama Han Yazılım Bilişim Hizmetleri